Immunic, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -4.1 | -100% |
| P/S |
|
0 | 33.75 | -100% |
|
|
| P/BV |
|
2.21 | 4.82 | -54.21% |
|
|
| P/FCF |
|
-1.01 | 61 | -101.65% |
|
|
| Ev/Ebitda |
|
-0.1865 | -22.17 | -99.16% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-0.2597 | 68.75 | -100.38% |
|
|
| E/P |
|
-1.3 | 0.0178 | -7414.18% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | -217561.11 | -100% |
| ROE |
|
-323.57 | 9.61 | -3466.46% |
|
|
| ROA |
|
-172.4 | 0.3443 | -50178.79% |
|
|
| ROIC |
|
-57.1 | 7.63 | -847.93% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-342.96 | 15.35 | -2334.25% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0135 | -3.68 | -99.63% | -0.0119 | +12.65% |
| Nеt Debt/Ebitda |
|
0.4575 | -3.44 | -113.31% |
|
|
| Debt/Ratio |
|
0.0246 | 0.1985 | -87.62% |
|
|
| Debt/Equity |
|
4.54 | 1.66 | 172.97% |
|
|
| Debt/Net Income |
|
-0.0143 | 10.32 | -100.14% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
168 | -54.68 | -407.24% | ||
| Growth impulse Net Income in 5 years |
|
167.46 | -58.33 | -387.09% | ||
| Growth impulse FCF in 5 years |
|
145.39 | -49.48 | -393.84% | ||
| Growth impulse EPS in 5 years |
|
-53.27 | -32.41 | 64.36% |
IP Score
3.52/10
